Global Dermal Fillers and Botulinum Toxin Market Report 2019, Competitive Landscape, Trends and Opportunities
The Dermal Fillers and Botulinum Toxin market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Dermal Fillers and Botulinum Toxin market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Dermal Fillers and Botulinum Toxin market.
Major players in the global Dermal Fillers and Botulinum Toxin market include:
Sanofi
HUGEL, Inc.
Galderma SA
Anika Therapeutics, Inc.
Merz Pharma GmbH & Co. KGaA
Speciality European Pharma
TEOXANE Laboratories
Hyaltech
Daewoong Pharmaceuticals
Medy-Tox Inc.
LG Life Sciences
SciVision Biotech Inc.
Suneva Medical, Inc.
Allergan plc.
Grex Pharma SaS
On the basis of types, the Dermal Fillers and Botulinum Toxin market is primarily split into:
Hyaluronic Acid Based Dermal Fillers
Non-hyaluronic Acid Based Dermal Fillers
Botulinum Toxin
On the basis of applications, the market covers:
Aesthetic Volume Restoration
Wrinkle Reduction
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Dermal Fillers and Botulinum Toxin market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Dermal Fillers and Botulinum Toxin market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Dermal Fillers and Botulinum Toxin industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Dermal Fillers and Botulinum Toxin market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Dermal Fillers and Botulinum Toxin, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Dermal Fillers and Botulinum Toxin in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Dermal Fillers and Botulinum Toxin in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Dermal Fillers and Botulinum Toxin. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Dermal Fillers and Botulinum Toxin market, including the global production and revenue forecast, regional forecast. It also foresees the Dermal Fillers and Botulinum Toxin market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Dermal Fillers and Botulinum Toxin market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Dermal Fillers and Botulinum Toxin market.
Major players in the global Dermal Fillers and Botulinum Toxin market include:
Sanofi
HUGEL, Inc.
Galderma SA
Anika Therapeutics, Inc.
Merz Pharma GmbH & Co. KGaA
Speciality European Pharma
TEOXANE Laboratories
Hyaltech
Daewoong Pharmaceuticals
Medy-Tox Inc.
LG Life Sciences
SciVision Biotech Inc.
Suneva Medical, Inc.
Allergan plc.
Grex Pharma SaS
On the basis of types, the Dermal Fillers and Botulinum Toxin market is primarily split into:
Hyaluronic Acid Based Dermal Fillers
Non-hyaluronic Acid Based Dermal Fillers
Botulinum Toxin
On the basis of applications, the market covers:
Aesthetic Volume Restoration
Wrinkle Reduction
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Dermal Fillers and Botulinum Toxin market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Dermal Fillers and Botulinum Toxin market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Dermal Fillers and Botulinum Toxin industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Dermal Fillers and Botulinum Toxin market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Dermal Fillers and Botulinum Toxin, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Dermal Fillers and Botulinum Toxin in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Dermal Fillers and Botulinum Toxin in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Dermal Fillers and Botulinum Toxin. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Dermal Fillers and Botulinum Toxin market, including the global production and revenue forecast, regional forecast. It also foresees the Dermal Fillers and Botulinum Toxin market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 DERMAL FILLERS AND BOTULINUM TOXIN MARKET OVERVIEW
1.1 Product Overview and Scope of Dermal Fillers and Botulinum Toxin
1.2 Dermal Fillers and Botulinum Toxin Segment by Type
1.2.1 Global Dermal Fillers and Botulinum Toxin Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Hyaluronic Acid Based Dermal Fillers
1.2.3 The Market Profile of Non-hyaluronic Acid Based Dermal Fillers
1.2.4 The Market Profile of Botulinum Toxin
1.3 Global Dermal Fillers and Botulinum Toxin Segment by Application
1.3.1 Dermal Fillers and Botulinum Toxin Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Aesthetic Volume Restoration
1.3.3 The Market Profile of Wrinkle Reduction
1.4 Global Dermal Fillers and Botulinum Toxin Market by Region (2014-2026)
1.4.1 Global Dermal Fillers and Botulinum Toxin Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3 Europe Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.1 Germany Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.2 UK Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.3 France Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.4 Italy Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.5 Spain Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.6 Russia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.7 Poland Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.4 China Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.5 Japan Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.6 India Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.8 Central and South America Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Dermal Fillers and Botulinum Toxin (2014-2026)
1.5.1 Global Dermal Fillers and Botulinum Toxin Revenue Status and Outlook (2014-2026)
1.5.2 Global Dermal Fillers and Botulinum Toxin Production Status and Outlook (2014-2026)
2 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN MARKET LANDSCAPE BY PLAYER
2.1 Global Dermal Fillers and Botulinum Toxin Production and Share by Player (2014-2019)
2.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Player (2014-2019)
2.3 Global Dermal Fillers and Botulinum Toxin Average Price by Player (2014-2019)
2.4 Dermal Fillers and Botulinum Toxin Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Dermal Fillers and Botulinum Toxin Market Competitive Situation and Trends
2.5.1 Dermal Fillers and Botulinum Toxin Market Concentration Rate
2.5.2 Dermal Fillers and Botulinum Toxin Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Sanofi
3.1.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.1.3 Sanofi Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.1.4 Sanofi Business Overview
3.2 HUGEL, Inc.
3.2.1 HUGEL, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.2.3 HUGEL, Inc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.2.4 HUGEL, Inc. Business Overview
3.3 Galderma SA
3.3.1 Galderma SA Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.3.3 Galderma SA Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.3.4 Galderma SA Business Overview
3.4 Anika Therapeutics, Inc.
3.4.1 Anika Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.4.3 Anika Therapeutics, Inc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.4.4 Anika Therapeutics, Inc. Business Overview
3.5 Merz Pharma GmbH & Co. KGaA
3.5.1 Merz Pharma GmbH & Co. KGaA Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.5.3 Merz Pharma GmbH & Co. KGaA Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.5.4 Merz Pharma GmbH & Co. KGaA Business Overview
3.6 Speciality European Pharma
3.6.1 Speciality European Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.6.3 Speciality European Pharma Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.6.4 Speciality European Pharma Business Overview
3.7 TEOXANE Laboratories
3.7.1 TEOXANE Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.7.3 TEOXANE Laboratories Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.7.4 TEOXANE Laboratories Business Overview
3.8 Hyaltech
3.8.1 Hyaltech Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.8.3 Hyaltech Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.8.4 Hyaltech Business Overview
3.9 Daewoong Pharmaceuticals
3.9.1 Daewoong Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.9.3 Daewoong Pharmaceuticals Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.9.4 Daewoong Pharmaceuticals Business Overview
3.10 Medy-Tox Inc.
3.10.1 Medy-Tox Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.10.3 Medy-Tox Inc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.10.4 Medy-Tox Inc. Business Overview
3.11 LG Life Sciences
3.11.1 LG Life Sciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.11.3 LG Life Sciences Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.11.4 LG Life Sciences Business Overview
3.12 SciVision Biotech Inc.
3.12.1 SciVision Biotech Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.12.3 SciVision Biotech Inc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.12.4 SciVision Biotech Inc. Business Overview
3.13 Suneva Medical, Inc.
3.13.1 Suneva Medical, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.13.3 Suneva Medical, Inc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.13.4 Suneva Medical, Inc. Business Overview
3.14 Allergan plc.
3.14.1 Allergan plc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.14.3 Allergan plc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.14.4 Allergan plc. Business Overview
3.15 Grex Pharma SaS
3.15.1 Grex Pharma SaS Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.15.3 Grex Pharma SaS Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.15.4 Grex Pharma SaS Business Overview
4 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Dermal Fillers and Botulinum Toxin Production and Market Share by Type (2014-2019)
4.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Type (2014-2019)
4.3 Global Dermal Fillers and Botulinum Toxin Price by Type (2014-2019)
4.4 Global Dermal Fillers and Botulinum Toxin Production Growth Rate by Type (2014-2019)
4.4.1 Global Dermal Fillers and Botulinum Toxin Production Growth Rate of Hyaluronic Acid Based Dermal Fillers (2014-2019)
4.4.2 Global Dermal Fillers and Botulinum Toxin Production Growth Rate of Non-hyaluronic Acid Based Dermal Fillers (2014-2019)
4.4.3 Global Dermal Fillers and Botulinum Toxin Production Growth Rate of Botulinum Toxin (2014-2019)
5 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN MARKET ANALYSIS BY APPLICATION
5.1 Global Dermal Fillers and Botulinum Toxin Consumption and Market Share by Application (2014-2019)
5.2 Global Dermal Fillers and Botulinum Toxin Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Dermal Fillers and Botulinum Toxin Consumption Growth Rate of Aesthetic Volume Restoration (2014-2019)
5.2.2 Global Dermal Fillers and Botulinum Toxin Consumption Growth Rate of Wrinkle Reduction (2014-2019)
6 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Dermal Fillers and Botulinum Toxin Consumption by Region (2014-2019)
6.2 United States Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.3 Europe Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.4 China Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.5 Japan Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.6 India Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
7 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Dermal Fillers and Botulinum Toxin Production and Market Share by Region (2014-2019)
7.2 Global Dermal Fillers and Botulinum Toxin Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
8 DERMAL FILLERS AND BOTULINUM TOXIN MANUFACTURING ANALYSIS
8.1 Dermal Fillers and Botulinum Toxin Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Dermal Fillers and Botulinum Toxin Industrial Chain Analysis
9.2 Raw Materials Sources of Dermal Fillers and Botulinum Toxin Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Dermal Fillers and Botulinum Toxin
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN MARKET FORECAST (2019-2026)
11.1 Global Dermal Fillers and Botulinum Toxin Production, Revenue Forecast (2019-2026)
11.1.1 Global Dermal Fillers and Botulinum Toxin Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Dermal Fillers and Botulinum Toxin Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Dermal Fillers and Botulinum Toxin Price and Trend Forecast (2019-2026)
11.2 Global Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Dermal Fillers and Botulinum Toxin Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Dermal Fillers and Botulinum Toxin Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Dermal Fillers and Botulinum Toxin
1.2 Dermal Fillers and Botulinum Toxin Segment by Type
1.2.1 Global Dermal Fillers and Botulinum Toxin Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Hyaluronic Acid Based Dermal Fillers
1.2.3 The Market Profile of Non-hyaluronic Acid Based Dermal Fillers
1.2.4 The Market Profile of Botulinum Toxin
1.3 Global Dermal Fillers and Botulinum Toxin Segment by Application
1.3.1 Dermal Fillers and Botulinum Toxin Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Aesthetic Volume Restoration
1.3.3 The Market Profile of Wrinkle Reduction
1.4 Global Dermal Fillers and Botulinum Toxin Market by Region (2014-2026)
1.4.1 Global Dermal Fillers and Botulinum Toxin Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3 Europe Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.1 Germany Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.2 UK Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.3 France Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.4 Italy Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.5 Spain Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.6 Russia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.3.7 Poland Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.4 China Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.5 Japan Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.6 India Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.8 Central and South America Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Dermal Fillers and Botulinum Toxin Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Dermal Fillers and Botulinum Toxin (2014-2026)
1.5.1 Global Dermal Fillers and Botulinum Toxin Revenue Status and Outlook (2014-2026)
1.5.2 Global Dermal Fillers and Botulinum Toxin Production Status and Outlook (2014-2026)
2 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN MARKET LANDSCAPE BY PLAYER
2.1 Global Dermal Fillers and Botulinum Toxin Production and Share by Player (2014-2019)
2.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Player (2014-2019)
2.3 Global Dermal Fillers and Botulinum Toxin Average Price by Player (2014-2019)
2.4 Dermal Fillers and Botulinum Toxin Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Dermal Fillers and Botulinum Toxin Market Competitive Situation and Trends
2.5.1 Dermal Fillers and Botulinum Toxin Market Concentration Rate
2.5.2 Dermal Fillers and Botulinum Toxin Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Sanofi
3.1.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.1.3 Sanofi Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.1.4 Sanofi Business Overview
3.2 HUGEL, Inc.
3.2.1 HUGEL, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.2.3 HUGEL, Inc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.2.4 HUGEL, Inc. Business Overview
3.3 Galderma SA
3.3.1 Galderma SA Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.3.3 Galderma SA Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.3.4 Galderma SA Business Overview
3.4 Anika Therapeutics, Inc.
3.4.1 Anika Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.4.3 Anika Therapeutics, Inc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.4.4 Anika Therapeutics, Inc. Business Overview
3.5 Merz Pharma GmbH & Co. KGaA
3.5.1 Merz Pharma GmbH & Co. KGaA Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.5.3 Merz Pharma GmbH & Co. KGaA Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.5.4 Merz Pharma GmbH & Co. KGaA Business Overview
3.6 Speciality European Pharma
3.6.1 Speciality European Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.6.3 Speciality European Pharma Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.6.4 Speciality European Pharma Business Overview
3.7 TEOXANE Laboratories
3.7.1 TEOXANE Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.7.3 TEOXANE Laboratories Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.7.4 TEOXANE Laboratories Business Overview
3.8 Hyaltech
3.8.1 Hyaltech Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.8.3 Hyaltech Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.8.4 Hyaltech Business Overview
3.9 Daewoong Pharmaceuticals
3.9.1 Daewoong Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.9.3 Daewoong Pharmaceuticals Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.9.4 Daewoong Pharmaceuticals Business Overview
3.10 Medy-Tox Inc.
3.10.1 Medy-Tox Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.10.3 Medy-Tox Inc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.10.4 Medy-Tox Inc. Business Overview
3.11 LG Life Sciences
3.11.1 LG Life Sciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.11.3 LG Life Sciences Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.11.4 LG Life Sciences Business Overview
3.12 SciVision Biotech Inc.
3.12.1 SciVision Biotech Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.12.3 SciVision Biotech Inc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.12.4 SciVision Biotech Inc. Business Overview
3.13 Suneva Medical, Inc.
3.13.1 Suneva Medical, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.13.3 Suneva Medical, Inc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.13.4 Suneva Medical, Inc. Business Overview
3.14 Allergan plc.
3.14.1 Allergan plc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.14.3 Allergan plc. Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.14.4 Allergan plc. Business Overview
3.15 Grex Pharma SaS
3.15.1 Grex Pharma SaS Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Dermal Fillers and Botulinum Toxin Product Profiles, Application and Specification
3.15.3 Grex Pharma SaS Dermal Fillers and Botulinum Toxin Market Performance (2014-2019)
3.15.4 Grex Pharma SaS Business Overview
4 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Dermal Fillers and Botulinum Toxin Production and Market Share by Type (2014-2019)
4.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Type (2014-2019)
4.3 Global Dermal Fillers and Botulinum Toxin Price by Type (2014-2019)
4.4 Global Dermal Fillers and Botulinum Toxin Production Growth Rate by Type (2014-2019)
4.4.1 Global Dermal Fillers and Botulinum Toxin Production Growth Rate of Hyaluronic Acid Based Dermal Fillers (2014-2019)
4.4.2 Global Dermal Fillers and Botulinum Toxin Production Growth Rate of Non-hyaluronic Acid Based Dermal Fillers (2014-2019)
4.4.3 Global Dermal Fillers and Botulinum Toxin Production Growth Rate of Botulinum Toxin (2014-2019)
5 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN MARKET ANALYSIS BY APPLICATION
5.1 Global Dermal Fillers and Botulinum Toxin Consumption and Market Share by Application (2014-2019)
5.2 Global Dermal Fillers and Botulinum Toxin Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Dermal Fillers and Botulinum Toxin Consumption Growth Rate of Aesthetic Volume Restoration (2014-2019)
5.2.2 Global Dermal Fillers and Botulinum Toxin Consumption Growth Rate of Wrinkle Reduction (2014-2019)
6 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Dermal Fillers and Botulinum Toxin Consumption by Region (2014-2019)
6.2 United States Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.3 Europe Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.4 China Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.5 Japan Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.6 India Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Dermal Fillers and Botulinum Toxin Production, Consumption, Export, Import (2014-2019)
7 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Dermal Fillers and Botulinum Toxin Production and Market Share by Region (2014-2019)
7.2 Global Dermal Fillers and Botulinum Toxin Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Dermal Fillers and Botulinum Toxin Production, Revenue, Price and Gross Margin (2014-2019)
8 DERMAL FILLERS AND BOTULINUM TOXIN MANUFACTURING ANALYSIS
8.1 Dermal Fillers and Botulinum Toxin Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Dermal Fillers and Botulinum Toxin Industrial Chain Analysis
9.2 Raw Materials Sources of Dermal Fillers and Botulinum Toxin Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Dermal Fillers and Botulinum Toxin
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL DERMAL FILLERS AND BOTULINUM TOXIN MARKET FORECAST (2019-2026)
11.1 Global Dermal Fillers and Botulinum Toxin Production, Revenue Forecast (2019-2026)
11.1.1 Global Dermal Fillers and Botulinum Toxin Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Dermal Fillers and Botulinum Toxin Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Dermal Fillers and Botulinum Toxin Price and Trend Forecast (2019-2026)
11.2 Global Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Dermal Fillers and Botulinum Toxin Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Dermal Fillers and Botulinum Toxin Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Dermal Fillers and Botulinum Toxin Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
